http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0#Head
http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0#assertion
http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0#provenance
http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0#pubinfo
http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0#assertion
http://purl.obolibrary.org/obo/DOID_3078
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_3078
http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB00853
http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0#association
http://www.w3.org/2000/01/rdf-schema#label
temozolomide capsules are an alkylating drug indicated for the treatment of adult patients with newly diagnosed glioblastoma multiforme gbm concomitantly with radiotherapy and then as maintenance treatment 1 1 refractory anaplastic astrocytoma patients who have experienced disease progression on a drug regimen containing nitrosourea and procarbazine 1 2 temozolomide capsules are indicated for the treatment of adult patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as maintenance treatment temozolomide capsules are indicated for the treatment of adult patients with refractory anaplastic astrocytoma i e patients who have experienced disease progression on a drug regimen containing nitrosourea and procarbazine
http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0#association
https://w3id.org/biolink/vocab/relation
https://schema.org/TreatmentIndication
https://identifiers.org/drugbank:DB00853
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0#provenance
http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0#pubinfo
http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0#sig
http://purl.org/nanopub/x/hasSignature
fNfZrtG+k2qx5pKlQKatBfi44u1ikkOMfBSszrwbFXO4c8oDneCPxq09WFD8fL/AiamWX4NXHl2jmJ5KWpWJk0gsbCEqxCcuw6zT6Sz6AtAi8tn7hBIAllso8gIX7QoHnGqdzDsEjLPqJGIrmsVxThMmNYlOEoWqAVmB5vnjNA4=
http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0
http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0
http://purl.org/dc/terms/created
2021-06-12T16:49:29.885+02:00
http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs